Brief IA
›

Anthropic: Claude Designs Proteins with Announced 35% Success Rate

Models & LLM·Tom Levy·

Anthropic: Claude Designs Proteins with Announced 35% Success Rate

Anthropic: Claude Designs Proteins with Announced 35% Success Rate
Key Takeaways
1Anthropic claims that an LLM agent can handle the entire design of proteins.
2Up to 35% success reported, compared to an average of 10 to 15% in the industry.
3An independent evaluation is still pending.
Why it matters : Targeting biological targets is a key step in early drug development.

Anthropic claims that any laboratory can now entrust the entire protein design process to an agent based on a language model. The company states that it has used its Claude models to autonomously generate small proteins.

La lettre du soirGratuit · 19 h

Le brief IA que les pros lisent chaque soir

Les 7 actus IA du jour, décryptées en 5 min. Gratuit.

Inclus dès l'inscription : notre sélection des meilleurs guides & comparatifs IA.

Choisissez votre rythme

Gratuit · Pas de spam · Désabonnement en 1 clic

Independent evaluation pending, externally driven tools

An independent evaluation is still awaited. Claude has only piloted specialized tools that are already available. Anthropic reports a success rate of up to 35%, compared to an industry average of between 10 and 15%.

Binding to a target, a key step in early R&D

The sequences aim to bind to target structures in the body. This step is crucial for early drug development.

Brief IA — L'actualité IA en français

L'essentiel de l'actualité de l'intelligence artificielle, décrypté et expliqué chaque jour.